Tag: EU approval
Daratumumab Quadruplet for Newly Diagnosed Myeloma: EU Approval Update
The European Medicines Agency's Committee for Medicinal Products for Human Use has recommended the approval of subcutaneous daratumumab plus VRd for patients with newly...